[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kanke et al., 1992 - Google Patents

Application of curdlan to controlled drug delivery. I. The preparation and evaluation of theophylline-containing curdlan tablets

Kanke et al., 1992

Document ID
17762736536522880319
Author
Kanke M
Koda K
Koda Y
Katayama H
Publication year
Publication venue
Pharmaceutical research

External Links

Snippet

To study the use of curdlan, a natural β-l, 3-glucan, in drug delivery, in vitro release studies were carried out with curdlan tablets containing theophylline. Tablets were readily prepared by compressing three different curdlan and theophylline mixtures, namely, a physical …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Similar Documents

Publication Publication Date Title
CA2414945C (en) Cellulose powder
Bodmeier et al. Spherical agglomerates of water‐insoluble drugs
JP4213867B2 (en) Method for preparing oral calcium composition
EP1873196B1 (en) Porous cellulose aggregate and molding composition thereof
JP2628231B2 (en) Konjac glucomannan readily available as a release-controlling excipient
EP2210591B1 (en) Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
NO321771B1 (en) Excipient composition, aqueous slurry composition and process for preparing an excipient.
CN102271664B (en) Controlled release pharmaceutical or food formulation and process for preparation thereof
JP5650532B2 (en) New excipient for mannitol tableting
JPH06500576A (en) controlled release verapamil tablets
NO320533B1 (en) Pharmaceutical excipient compositions having improved compressibility, a solid dosage form composition with the excipient, an aqueous slurry useful in the preparation of a compressible pharmaceutical excipient, and a process for the preparation of said dosage form.
JP3534130B2 (en) Pharmaceutical composition
Kanke et al. Application of curdlan to controlled drug delivery. I. The preparation and evaluation of theophylline-containing curdlan tablets
WO2000003735A1 (en) Excipient
JP3568567B2 (en) High moldability excipient and method for producing the same
JPH05170669A (en) Excipient for tablet
KR100232020B1 (en) Sustained release excipient
AU2009279619A1 (en) Sustained release compositions comprising gums and sugar alcohols
JPWO2004006945A1 (en) Kampo extract-containing tablet composition and method for producing the same
Klinger et al. Formulation of controlled release matrices by granulation with a polymer dispersion
CN103169706A (en) Compound oral disintegrating tablet containing acetaminophen and dextromethorphan
JP2005255617A (en) Solid pharmaceutical preparation composition comprising fine particulate active ingredient and porous cellulose aggregate
US20110064818A1 (en) Pharmaceutical composition and a method for the production thereof
EP2467027B1 (en) Process for compressing isomalt
AU5830399A (en) Pharmaceutical excipient having improved compressibility